Baird on Amgen's (AMGN) Blow-out Q2: Not Same Old Risk/Reward, But See Mid-$80's Near-Term
Tweet Send to a Friend
Baird reiterates an 'Outperform' on Amgen (NASDAQ: AMGN) price target of $83.00.
Analyst, Christopher Raymond, said, "While we continue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Christopher Raymond, said, "While we continue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
